Reproducibility of inhaled and subcutaneous insulin in Type 2 diabetic patients

被引：0
|
作者：
Perera, AD
Kapitza, C
Nosek, L
Heinemann, LW
Shapiro, DA
Fishman, RS
Heise, TC
机构：
[1] Aerogen Inc, Sunnyvale, CA USA
[2] Profil Inst Metab Res, Neuss, Germany
来源：
DIABETOLOGIA | 2001年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
815
引用
收藏
页码：A212 / A212
页数：1
相关论文
共 50 条
  • [21] Pharmacological reproducibility of inhaled human insulin pre-meal dosing in patients with type 2 diabetes mellitus (NIDDM)
    Gelfand, RA
    Schwartz, SL
    Horton, M
    Law, CG
    Pun, EF
    DIABETES, 1998, 47 : A99 - A99
  • [22] Reduced hypoglycaemia is observed with inhaled insulin versus subcutaneous insulin aspart in patients with type 1 diabetes mellitus
    Nikonova, E.
    Bode, B.
    Gill, J.
    Stewart, J.
    Blonde, L.
    DIABETOLOGIA, 2015, 58 : S449 - S450
  • [23] Combination of continuous subcutaneous infusion of insulin and octreotide in Type 1 diabetic patients
    Bruttomesso, D
    Fongher, C
    Silvestri, B
    Barberio, S
    Marescotti, MC
    Iori, E
    Valerio, A
    Crazzolara, D
    Pianta, A
    Tiengo, A
    Del Prato, S
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 51 (02) : 97 - 105
  • [24] Treatment Efficacy of Subcutaneous Insulin Infusion Therapy In Type 1 Diabetic Patients
    Cander, Soner
    Kiyici, Sinem
    Deligonul, Adem
    Gul, Ozen Oz
    Uonal, Oguz Kaan
    Sakalli, Mustafa
    Tuncel, Ercan
    Imamoglu, Sazi
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2010, 14 (04) : 80 - 84
  • [25] The comparison of insulin aspart and human soluble insulin used in continuous subcutaneous insulin infusion in newly diagnosed type 2 diabetic patients
    Li, Y
    Liu, J
    Liao, Z
    Huang, ZM
    Weng, HP
    DIABETES, 2005, 54 : A106 - A107
  • [26] SUBCUTANEOUS PERITONEAL ACCESS DEVICE FOR TYPE-I DIABETIC-PATIENTS NONRESPONSIVE TO SUBCUTANEOUS INSULIN
    SCHADE, DS
    EATON, RP
    WARHOL, RM
    GREGORY, JA
    DOBERNECK, RC
    DIABETES, 1982, 31 (05) : 470 - 473
  • [27] Inhaled insulin therapy in a boy with type 1 diabetes and severe subcutaneous insulin resistance
    Velden, Adriana Van Alfen-van der
    Noordam, Cees
    De Galan, Bastiaan
    Westerlaken, Ciska
    HORMONE RESEARCH, 2008, 70 : 201 - 201
  • [28] Insulin Requirement Profiles of Short-Term Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 2 Diabetic Nephropathy
    Feng, Qianqiu
    Li, Biyun
    Lin, Jiating
    Zou, Li
    Xu, Wen
    Zeng, Longyi
    Li, Ping
    Lin, Shuo
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2025, 2025 (01)
  • [29] Within-subject variability of inhaled insulin (Exubera®) versus subcutaneous regular insulin in elderly obese patients with type 2 diabetes Mellitus
    Henry, R
    Mudaliar, S
    Fryburg, D
    Becker, R
    Willavize, S
    Fisher, J
    Fountaine, R
    Sha, S
    DIABETES, 2003, 52 : A105 - A105
  • [30] Mechanism of action of inhaled insulin Exubera® to normalise the fasting plasma glucose concentration in type 2 diabetic patients
    Mehta, R. J.
    Ricotti, A.
    Balas, B.
    Gastaldelli, A.
    De Fronzo, R. A.
    Tripathy, D.
    DIABETOLOGIA, 2011, 54 : S417 - S417
12345